| Mrs Tammi Joanne Nokes, MS, CCC-SLP | |
|
926 E E St, Hastings, NE 68901-6617 | |
| (402) 463-3181 | |
| Not Available |
| Full Name | Mrs Tammi Joanne Nokes |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 926 E E St, Hastings, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427240506 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1222 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tammi Joanne Nokes, MS, CCC-SLP 601 Dockside Cv, Hastings, NE 68901-2557 Ph: (402) 462-8763 | Mrs Tammi Joanne Nokes, MS, CCC-SLP 926 E E St, Hastings, NE 68901-6617 Ph: (402) 463-3181 |
News Archive
By global standards, health risks caused by environmental factors are low in the United Arab Emirates (UAE), new studies by University of North Carolina at Chapel Hill researchers show.
Detroit Medical Center (DMC) officials today made good on their promise to get right to work on hospital construction projects, announcing contracts totaling over $60 million just four days after DMC's landmark partnership with Vanguard Health Systems was sealed.
Lancet Infectious Diseases Newsdesk examines how despite evidence that a new therapy to treat sleeping sickness, called nifurtimox—eflornithine (NECT) is a step forward in treating the disease, it has yet to be implemented by countries "13 months after data from a successful trial was presented." The main issue at hand - "nifurtimox is not registered for use in sleeping sickness," the journal writes. The article also examines other factors complicating the implementation of the therapy (Morris, 12/09).
NeuroDerm, Ltd. announced today that enrollment of healthy subjects is ongoing in its Phase I clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously via a subcutaneous delivery patch device. It is designed to provide steady levodopa blood levels and enhanced bioavailability of oral levodopa for the reduction of motor complications in Parkinson's disease.
› Verified 2 days ago
Heidi Tunks, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1924 W A St, Hastings, NE 68901 Phone: 402-461-7578 | |
Haylee Nicole Sheffield, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3601 Cimarron Plz Ste 105, Hastings, NE 68901 Phone: 402-463-2077 Fax: 402-463-2062 | |
Susan Conner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1117 E South St, Hastings, NE 68901 Phone: 402-463-5611 | |
Holly Vanderpool, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1924 W A St, Hastings, NE 68901 Phone: 402-461-7578 | |
Speech Language And Learning Place Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 240 West 94th Street, Hastings, NE 68902 Phone: 402-744-2091 Fax: 402-744-2092 | |
Deann Smith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1924 W A St, Hastings, NE 68901 Phone: 405-461-7578 | |
Brooke West, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 835 S Burlington Ave Ste 110, Hastings, NE 68901 Phone: 402-463-2077 Fax: 402-463-2062 |